Real-time Estimate
Other stock markets
|
5-day change | 1st Jan Change | ||
67.1 USD | +0.10% | +0.04% | -17.35% |
Apr. 23 | Argus Cuts Price Target on Gilead Sciences to $75 From $85 | MT |
Apr. 22 | Cantor Fitzgerald Adjusts Gilead Sciences' Price Target to $75 From $78, Maintains Neutral Rating | MT |
This article is reserved for members
Already a member?
Log InNot a member ?
Free registrationEPS Revisions
1st Jan change | Capi. | |
---|---|---|
-17.35% | 83.58B | |
+25.54% | 672B | |
+25.87% | 570B | |
-5.76% | 360B | |
+16.13% | 321B | |
+8.71% | 300B | |
+7.09% | 217B | |
-9.12% | 204B | |
+5.01% | 199B | |
-9.17% | 149B |
- Stock Market
- Equities
- GILD Stock
- News Gilead Sciences, Inc.
- Gilead Sciences : Credit Suisse Adjusts Gilead Sciences' Price Target to $69 from $65, Keeps Neutral Rating